Under construction – not a live service
Sign in
Taking people in PolandNo phase

Measures microplastics in samples from children with and without bowel disease

Compares microplastics in samples from children with inflammatory bowel disease and without it.

Plain-language title generated from the registry record
Registry title: Microplastic Analysis in Pediatric Inflammatory Bowel Disease

Key facts

Where
Gdansk, PolandSee the site

Where in Poland

  • Medical University of Gdańsk, Department of Pediatrics, Gastroenterology, Allergolgy and NutritionGdansk, PolandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Medical University of Gdansk
Trial code
NCT07141238
Record updated
30 September 2025
Original description
The goal of this observational study is to measure and compare the presence of microplastics in children with inflammatory bowel disease (IBD) and children without IBD. The main questions it aims to answer are:Read full original descriptionShow less

Analysis of Microplastics in Pediatric Inflammatory Bowel Disease Using Raman Spectroscopy: A Multi-Matrix Study

The goal of this observational study is to measure and compare the presence of microplastics in children with inflammatory bowel disease (IBD) and children without IBD. The main questions it aims to answer are:

Are microplastics detectable in different biological samples from children? Are there differences in microplastic burden between children with and without IBD?

Researchers will collect biological samples including: intestinal tissue (from routine endoscopy), stool, urine, blood.

Raman spectroscopy will be used to detect and characterize microplastics in each sample type. Participants will not receive any medication or intervention as part of this study. All samples will be collected during standard clinical procedures.

Inclusion: Age <18 years; Undergoing clinically indicated gastrointestinal endoscopy; For IBD group: confirmed diagnosis of Crohn's disease or ulcerative colitis; For control group: no current or past diagnosis of IBD.

Exclusion: Age 18 years or older; Lack of written assent from the participant if age ≥13 years; Lack of informed consent from legal guardian.

ClinicalTrials.gov NCT07141238